NEUROLOGY16 1.0
Continue to app
Free Version
Publisher Description
The clinical symptoms of neurodegenerative diseases arise years after the onset of neuronal damage. By the time the patient receives a diagnosis, it might be too late to intervene and modify the advanced pathological state of disease. Researchers are now focusing on preventing and stopping the pathological processes in the brain at an earlier, asymptomatic state. This conference aims to disseminate cutting-edge findings on preclinical neurodegenerative diseases including Alzheimer s disease, Parkinson s disease, amyotrophic lateral sclerosis, and Huntington s disease. The event will provide a unique platform for specialists to come together across disciplines for an authoritative discussion of the methodological, regulatory, and ethical considerations of research in people at asymptomatic states of neurodegenerative disease. A high level invited oral programme, supplemented by contributed posters will provide a complete update on the latest research and thinking on the following topics: Genetic factors, cellular pathways, and neuronal vulnerability Environmental factors, epidemiology, and primary prevention Biomarkers and early diagnosis Prevention through therapeutics Trials; regulatory and ethical considerations The event will also have a translational focus, exploring genetic susceptibility, epidemiology and risk factors, neuronal vulnerability, biomarkers and early diagnosis, and disease prevention in healthy individuals with both pharmacological and non-pharmacological interventions. Attendance at this meeting will enable you to: Be part of a rich scientific programme incorporating the latest developments in preclinical neurodegenerative diseases Understand the shift towards prevention and early diagnosis of neurodegenerative disease as the future of research in the field Join key opinion leaders in discussing regulatory and ethical implications of this research in clinical practice. Network with speakers and other leading experts across disciplines. Using Elsevier's new NEUROLOGY16 app, you can browse the scientific programme by days, topic or speaker, create your own personal programme, locate rooms and exhibitor stands on the floor plans, and more. Before first use, you will need to download the latest conference data and then afterwards, you can use the app offline.
Requires iOS 7.1 or later. Compatible with iPhone, iPad, and iPod touch.
About NEUROLOGY16
NEUROLOGY16 is a free app for iOS published in the Kids list of apps, part of Education.
The company that develops NEUROLOGY16 is Elsevier Inc.. The latest version released by its developer is 1.0.
To install NEUROLOGY16 on your iOS device, just click the green Continue To App button above to start the installation process. The app is listed on our website since 2016-09-26 and was downloaded 4 times. We have already checked if the download link is safe, however for your own protection we recommend that you scan the downloaded app with your antivirus. Your antivirus may detect the NEUROLOGY16 as malware if the download link is broken.
How to install NEUROLOGY16 on your iOS device:
- Click on the Continue To App button on our website. This will redirect you to the App Store.
- Once the NEUROLOGY16 is shown in the iTunes listing of your iOS device, you can start its download and installation. Tap on the GET button to the right of the app to start downloading it.
- If you are not logged-in the iOS appstore app, you'll be prompted for your your Apple ID and/or password.
- After NEUROLOGY16 is downloaded, you'll see an INSTALL button to the right. Tap on it to start the actual installation of the iOS app.
- Once installation is finished you can tap on the OPEN button to start it. Its icon will also be added to your device home screen.
